|
|
Volumn 343, Issue 16, 2000, Pages 1178-1179
|
|
Oral hypoglycemic drugs for gestational diabetes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLORPROPAMIDE;
GLIBENCLAMIDE;
INSULIN;
ORAL ANTIDIABETIC AGENT;
SULFONYLUREA;
TOLBUTAMIDE;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
DIABETES CONTROL;
DIET THERAPY;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG HALF LIFE;
DRUG TRANSPORT;
EDITORIAL;
EXERCISE;
FETUS DEATH;
HUMAN;
HYPOGLYCEMIA;
INSULIN TREATMENT;
MACROSOMIA;
METABOLIC REGULATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PATHOPHYSIOLOGY;
PERINATAL MORTALITY;
PLACENTAL TRANSFER;
PREGNANCY DIABETES MELLITUS;
PRIORITY JOURNAL;
SCREENING;
TERATOGENICITY;
ABNORMALITIES;
BLOOD GLUCOSE;
DIABETES, GESTATIONAL;
FEMALE;
FETAL BLOOD;
FETAL MACROSOMIA;
GLYBURIDE;
HUMAN;
HYPOGLYCEMIC AGENTS;
INFANT, NEWBORN;
INSULIN;
PREGNANCY;
PREGNANCY OUTCOME;
SULFONYLUREA COMPOUNDS;
|
|
EID: 0034687443
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200010193431608 Document Type: Editorial |
|
Times cited : (42)
|
|
References (10)
|
